The following information is as of June 30, 2021.
The number of shares in issue is 84,719,345. The percentage of shares not in public hands is 16.1%. The list below is all disclosed holdings of 3% or larger.
|Rank||Shareholder / Registered holder||Shares||%|
|5||Amati Global Investors||2,942,572||3.5%|
|6||D1 Capital Partners||2,610,000||3.1%|
|8||Unicorn Asset Mgt||2,507,000||3.0%|
The Company currently has two lines of Common Stock admitted to trading on AIM: an unrestricted line of Common Stock trading under the symbol MXCT and a restricted line of Common Stock under the symbols MXCL and MXCN. MXCN is restricted under Regulation S Category 3 such that purchasers cannot sell or otherwise transfer such Common Stock except pursuant to the requirements of Regulation S until at least the expiry of one year after the closing of the offering which closed on 12 February 2021. There are no other restrictions on the transfer of AIM securities.
Rights of shareholders
The rights of shareholders are governed by UK law.
Restrictions in transfer of ordinary shares
There are no restrictions on the transfer of the company’s ordinary shares.
UK city code on takeover and mergers
The Company is not subject to the Takeover Code because its registered office and its place of central management and control are outside the UK, the Channel Islands and the Isle of Man. As a result, certain protections that are afforded to Shareholders under the UK Takeover Code, for example in relation to a takeover of a company or certain stakebuilding activities by shareholders, do not apply to the Company. Although the Company has inserted certain provisions into the Certificate of Incorporation which adopt similar procedures to the UK Takeover Code in the event of any party (or parties acting in concert) obtaining 30 per cent, or more of the voting rights attaching to the issued Common Stock, there is no assurance that the courts of the State of Delaware will uphold or allow the enforcement of these provisions. Further details relating to these provisions are set out in paragraph 15 of Part 5 of the Company’s Admission document.
Other exchanges and trading platforms
The securities of the Company are traded on the AIM market operated by the London Stock Exchange plc. MaxCyte is also traded on the Nasdaq Global Select Market and is subject to the regulations of the U.S. Securities and Exchange Commission. SEC filings can be found here.